Browse studies

Find your next paid study

25,431 recruiting studies available now

Use of Vorinostat as GVHD Prophylaxis in Children, Adolescents, and Young Adults With Non-Malignant Disorders Undergoing Allogeneic Blood and Marrow Transplantation

This is a single-arm, open label, phase 2 study to determine the safety and efficacy of vorinostat without serotherapy as GVHD prophylaxis when combined with e…

GVHD

Estimated

~$75 – $3,000

Actual pay is set by the research site.

Sung Won ChoiNCT06995521

Observational

Development and Pilot Testing of a Novel Intervention to Reduce Cardiovascular Disease Risk Among Breast Cancer Survivors Living in Rural, Medically Underserved Communities

This study is testing a new program called WeCan-Rural, designed to help breast cancer survivors manage symptoms and build healthy habits like eating well, sta…

Breast Cancer SurvivorshipWeight ManagementCardiovascular (CV) Risk+1 more

Estimated

~$10 – $750

Actual pay is set by the research site.

Duke UniversityNCT07426952

Development of Functional and Structural Magnetic Resonance Imaging Techniques for the Study of Mood and Anxiety Disorders

This study is intended to help develop new MRI imaging techniques for studying mood and anxiety disorders. Researchers believe that depression and anxiety diso…

Mood DisordersAnxiety Disorders

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Mental Health (NIMH)NCT00397111

Observational

Checkpoint Inhibitor Associated Diabetes Mellitus: Early Recognition and Treatment (CERT) Project: A Pilot Study

To find out if taking a drug called infliximab (the "study drug") is safe and effective in reversing insulin dependence in CIADM.

Checkpoint InhibitorPilot StudyDiabetes Melletus

Estimated

~$10 – $750

Actual pay is set by the research site.

M.D. Anderson Cancer CenterNCT07257068

Phase 3

A Phase III, Randomized, Multi-site, Open-label Trial of BNT323/DB-1303 Versus Investigator's Choice of Chemotherapy in Previously Treated Patients With HER2- Expressing Recurrent Endometrial Cancer

The study is divided into two cohorts (Cohort 1 and Cohort 2), to which participants will be enrolled based on the amount of human epidermal growth factor rece…

Endometrial Cancer

Estimated

~$50 – $2,250

Actual pay is set by the research site.

BioNTech SENCT06340568

Observational

An e-Health Intervention for Fear of Progression in Women With Gynecologic or Breast Cancer

This clinical trial studies whether an intervention supported by technology (blended e-health intervention) works to improve fear of progression (FOP) in women…

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+15 more

Estimated

~$10 – $750

Actual pay is set by the research site.

TMS Investigations of the Human Visual System

Background: -The brain has two systems for recognizing objects. One system recognizes what an object is, and the other system recognizes where the object is l…

fMRIDorsal PathwayVentral Pathway

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Mental Health (NIMH)NCT01617408

Longitudinal Study of Individuals and Families With Aberrations in DDX41 or Similar Cancer Predisposition Variants

Background: Hereditary hematopoietic malignancy (HHM) syndromes are a group of inherited disorders that raises the risk of blood cancers. Many people with HHM…

Germline MutationMyelodysplastic SyndromesAcute Myeloid Leukemia

Estimated

~$10 – $675

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT07019155

Phase 2

Biotype-assigned Augmentation Approach in Resistant Late-Life Depression (BAARD): a Randomized Controlled Trial

The goal of this clinical trial is to test whether a personalized approach to treatment selection improves symptoms in older adults with treatment-resistant de…

Late Life Treatment Resistant DepressionDepression - Major Depressive DisorderTreatment Resistant Depression

Estimated

~$75 – $2,000

Actual pay is set by the research site.

Washington University School of MedicineNCT07810738

Phase 1

Phase I Dose Escalation Study of FGFR4 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory Rhabdomyosarcoma

Background: Rhabdomyosarcoma (RMS) is a cancer of soft tissues. It is the most common soft tissue sarcoma seen in children. RMS cancer cells have a protein ca…

Rhabdomyosarcoma

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06865664

Collection of Blood, Bone Marrow, Skin, Saliva, and Stool Samples From Healthy Volunteers Used for Comparative Analysis of Myeloid Malignancies

Background: Myelodysplastic syndromes (MDS) are disorders of blood stem cells that can develop into blood cancers. Treatment options are limited. To find bett…

Myelodysplastic Syndromes

Estimated

~$10 – $675

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT05588154

Phase 3

A Phase 3 Study of Dinutuximab Added to Intensive Multimodal Therapy for Children With Newly Diagnosed High-Risk Neuroblastoma

This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, …

Ganglioneuroblastoma, NodularNeuroblastoma

Estimated

~$50 – $1,350

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06172296